News About: R&D
Korean scientists discover new mechanism of AIMP2/p38
A team of Korean scientists say that they have found a new mechanism of AIMP2/p38, a scaffolding protein required for the assembly of the macromolecular tRNA synthetase complex.
The team, led by Kim Sung-hoon, a p...
Ilyang announces positive results for ilaprazole in phase 3 study
Ilyang Pharm announced on August 8 that it has completed a multinational Phase 3 clinical study for ilaprozole, a new proton pump inhibitor, in six South East Asian countries including Thailand, Malaysia and Singapore...
ImQuest receives two-year grant to develop pyrimidinedione product as anti-HIV topical microbicide
Samjin Pharm says that its AIDS treatment co-developer successfully acquired funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors a...
Novartis to conduct additional trial of Rasilez
Novartis Inc. plans to expand the clinical trial program with Rasilez (aliskiren) to study organ protection potential beyond the already shown powerful reduction of blood pressure, according to Novartis Korea.
Rasi...
Product licenses on gradual increase
A total of eight licenses for prescription medicines were filed last month amid implementation of validation system, according to the Korea Food and Drug Administration.
Pharmaceutical companies are now hesitant to...
Whanin to market quetiapine 1000 mg
Whanin Pharm says it will sell quetiapine 1000 mg in addition to its strengths of 25 mg and 200 mg from August 1.
Whanin’s first version of antipsychotic Seroquel generic would be a major setback for AstraZeneca Ko...
Domestic pharmaceutical firms to nurture cGMP professionals
Korean companies will be able to bet on the possibility of mutual recognition arrangement (MRA) on generic drugs following the free trade agreement (FTA) ratification with the United States.
However, there are gro...
NKBio files patent application for new atherosclerosis treatment
NKBio says it has filed its domestic patent application for cytokeratin-1 compound, a potential drug candidate in the prevention and treatment of atherosclerosis.
The company notes that cytokeratin-1, which is asso...
Cervarix, GSK's cervical cancer vaccine, approved in Korea
GlaxoSmithKline (GSK) says that the Korea Food and Drug Administration has granted a marketing authorization for its cervical cancer vaccine, Cervarix.
Cervarix, with its innovative AS04 adjuvant system, is indica...
Lilly Korea launches ActosMet
Lilly Korea says it has launched its ActosMet (Actos 15 mg + metformin 850 mg) tablets for treatment of 2 diabetes - namely insulin resistance.
Actos is a clinically proven, once a day medicine that belongs to a cl...
